Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth

Ying Shi1, Guo-Bin Chen1, Xiao-Xiao Huang1

  • 1Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian Province, China.

Oncotarget
|June 2, 2015
PubMed

Insights

Dragon, a repulsive guidance molecule, promotes colorectal cancer (CRC) growth by activating bone morphogenetic protein (BMP) signaling. This finding reveals Dragon as a potential therapeutic target for treating CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer death, with poorly understood molecular drivers.
  • Dragon (RGMb), a repulsive guidance molecule, acts as a bone morphogenetic protein (BMP) co-receptor.
  • The role of Dragon in colorectal cancer development remains undefined.

Purpose of the Study:

  • To investigate the role of Dragon in colorectal cancer initiation, growth, and metastasis.
  • To elucidate the molecular pathways through which Dragon influences colorectal cancer progression.

Main Methods:

  • Dragon expression analysis in colon cancer tissues from a CAC mouse model and human patients.
  • In vitro proliferation assays using CT26.WT and CMT93 colon cancer cells.
  • In vivo tumor growth assessment in a xenograft mouse model.
  • Analysis of BMP4-Smad1/5/8 and Erk1/2 signaling pathways.

Main Results:

  • Dragon expression is significantly increased in colon cancer tissues compared to controls.
  • Dragon overexpression enhances colon cancer cell proliferation and accelerates tumor growth.
  • Dragon mediates its effects on colorectal cancer via the BMP4-Smad1/5/8 and Erk1/2 pathways.

Conclusions:

  • Dragon is a novel gene that promotes colorectal cancer growth.
  • Dragon's pro-tumorigenic activity is linked to BMP signaling.
  • Dragon represents a potential therapeutic target for colorectal cancer treatment.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K